CONTENTS
Issue 85 | August 2019
In association with
Understanding and treating the growing threat of drug-resistant tuberculosis
A look back at breakthrough moments in the hunt to prevent and treat HIV
Accusations of price fixing have added fuel to the fire of Teva's dramatic downfall
Exploring the dangers of clinics marketing unlicensed stem cell treatments
Research suggests that cancer cells can communicate further that we thought
How might Verona’s ensifentrine revolutionise treatment for COPD?
How can Big Pharma solve the problem of balancing patents and patients?
Introducing a ‘pay as you go’ database of AI programmes for drug discovery in the UK